Adobe has released an emergency security update for Acrobat Reader to fix a vulnerability, tracked as CVE-2026-34621, that ...
The gene-editing market is projected to grow to $30.8 billion by 2032, highlighting investment potential. CRISPR Therapeutics, co-founder by Charpentier, gains momentum with FDA-approved therapies.
CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the double ...